| John R Fischer, MD | |
|
44405 Woodward Avenue, St Joseph Mercy Hospital, Pontiac, MI 48341-2985 | |
| (248) 858-3190 | |
| (248) 858-3148 |
| Full Name | John R Fischer |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 44405 Woodward Avenue, Pontiac, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801841507 | NPI | - | NPPES |
| 3018161 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 054499 (Michigan) | Primary |
| Entity Name | Northwest Pathology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254909 PECOS PAC ID: 3678502671 Enrollment ID: O20050810000522 |
News Archive
When it comes to finding new treatments for disease, reinventing the wheel is not always necessary - drugs already in use for other conditions may do the job.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $2 million grant from the National Institute on Aging of the National Institutes of Health to study the effects of early nutrition on lifespan and overall health.
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
For the first time in the world, researchers at The University of Texas Health Science Center at Houston were able to enroll patients at other hospitals into an acute stroke clinical trial.
CeNeRx BioPharma, Inc., a clinical stage company developing innovative treatments for diseases of the central nervous system, today announced that a newly published PET imaging study in human subjects confirms that CeNeRx's novel compound TriRima(TM) reversibly inhibits MAO-A (monoamine oxidase A), an enzyme in the brain that plays a key role in the regulation of mood.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John R Fischer, MD Po Box 55114, Detroit, MI 48255 Ph: (248) 858-3197 | John R Fischer, MD 44405 Woodward Avenue, St Joseph Mercy Hospital, Pontiac, MI 48341-2985 Ph: (248) 858-3190 |
News Archive
When it comes to finding new treatments for disease, reinventing the wheel is not always necessary - drugs already in use for other conditions may do the job.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $2 million grant from the National Institute on Aging of the National Institutes of Health to study the effects of early nutrition on lifespan and overall health.
Advanced Biological Laboratories (ABL) S.A., a Luxembourg-based company today announced that it has entered into an exclusive worldwide licensing agreement with CRP-Santé, a Luxembourg-based public research center active in the field of clinically oriented biomedical research, for its COMET (COntext-based Modeling for Expeditious Typing) software, a tool designed to rapidly analyze and optimally subtype large genetic data sets arising from epidemiological or antiretroviral resistance in the human immunodeficiency virus (HIV) and hepatitis C virus (HCV) fields.
For the first time in the world, researchers at The University of Texas Health Science Center at Houston were able to enroll patients at other hospitals into an acute stroke clinical trial.
CeNeRx BioPharma, Inc., a clinical stage company developing innovative treatments for diseases of the central nervous system, today announced that a newly published PET imaging study in human subjects confirms that CeNeRx's novel compound TriRima(TM) reversibly inhibits MAO-A (monoamine oxidase A), an enzyme in the brain that plays a key role in the regulation of mood.
› Verified 5 days ago
Donald R Peven, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 44405 Woodward Ave, St Joseph Mercy Hospital, Pontiac, MI 48341 Phone: 248-858-3190 Fax: 248-858-3148 | |
James A Rising, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 461 West Huron Street, North Oakland Medical Center, Pontiac, MI 48341 Phone: 248-857-7287 Fax: 248-857-7051 | |
James W Furlong, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 44405 Woodward Avenue, St Joseph Mercy Hospital, Pontiac, MI 48341 Phone: 248-858-3190 Fax: 248-858-3148 | |
Kanubhai Virani, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1200 N Telegraph Rd, Pontiac, MI 48341 Phone: 248-858-4044 Fax: 248-452-9173 | |
Sherwin P Imlay, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 44405 Woodward Ave, St. Joseph Mercy Hospital, Pontiac, MI 48341 Phone: 248-858-3190 Fax: 248-858-3148 | |
Brian L Edelman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 461 West Huron Street, North Oakland Medical Center, Pontiac, MI 48341 Phone: 248-857-7287 Fax: 248-857-7051 |